PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-03-01

Date Title Company
01-Mar-2022 Counterfeit Drug Detection Device Market is estimated value of around US$ 1.14 Billion as of 2022 MARKITWIRED
01-Mar-2022 Cardiac Assist Devices Market is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Billion by 2031 MARKITWIRED
01-Mar-2022 Dosimetry Market SWOT Analysis, Key Indicators, Forecast 2029 : KEYPLAYERS – Honeywell, Thermo Fisher Scientific, Fortive Mirion Technologies, and Fuji Electric MARKITWIRED
01-Mar-2022 Medical X-Ray Detectors Market Recent Trends, Segment, Regional Analysis, Technology, Size and Forecast To 2029 MARKITWIRED
01-Mar-2022 Contraceptive Market is expected to reach ~US$ 33,529 Million by the end of 2029 MARKITWIRED
01-Mar-2022 Specialty Active Pharmaceutical Ingredients Market Recent Trends, Segment, Regional Analysis, Technology, Size and Forecast To 2030 MARKITWIRED
01-Mar-2022 Viscosupplementation Market revenues are likely to reach USD 4 billion by the end of 2030 MARKITWIRED
01-Mar-2022 Evolus Names Christos Monovoukas Senior Vice President of Corporate Development Businesswire
01-Mar-2022 Global Hemophilia Market Research Report to 2027 - by Type, Therapy and Region - ResearchAndMarkets.com Businesswire
01-Mar-2022 Stevanato Group Announces Agreement With BARDA for the Expansion of Vial Production to Create Industrial Base Capabilities for National Defense Businesswire
01-Mar-2022 TriMas Reports Fourth Quarter and Full Year 2021 Results Businesswire
01-Mar-2022 Seagen to Present at the Cowen 42nd Annual Health Care Conference Businesswire
01-Mar-2022 Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership Businesswire
01-Mar-2022 Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 10, 2022 Businesswire
01-Mar-2022 SelectQuote Introduces Healthcare Advisory Board Businesswire
01-Mar-2022 Ashvattha Therapeutics Announces Key Executive Appointments in Clinical Operations and Manufacturing Businesswire
01-Mar-2022 Mablink Bioscience announces appointment of its Chief Development Officer Businesswire
01-Mar-2022 IQVIA selected to accelerate clinical development of VYVGART™ (efgartigimod alfa fcab) by argenx SE Businesswire
01-Mar-2022 Thermo Fisher Scientific Continues Collaboration to Support Biopharmaceutical Discovery and Development Businesswire
01-Mar-2022 Equillium Announces Appointment of Barbara Troupin to Board of Directors Businesswire